Literature DB >> 10518505

A requirement for neuropilin-1 in embryonic vessel formation.

T Kawasaki1, T Kitsukawa, Y Bekku, Y Matsuda, M Sanbo, T Yagi, H Fujisawa.   

Abstract

Neuropilin-1 is a membrane protein that is expressed in developing neurons and functions as a receptor or a component of the receptor complex for the class 3 semaphorins, which are inhibitory axon guidance signals. Targeted inactivation of the neuropilin-1 gene in mice induced disorganization of the pathway and projection of nerve fibers, suggesting that neuropilin-1 mediates semaphorin-elicited signals and regulates nerve fiber guidance in embryogenesis. Neuropilin-1 is also expressed in endothelial cells and shown to bind vascular endothelial growth factor (VEGF), a potent regulator for vasculogenesis and angiogenesis. However, the roles of neuropilin-1 in vascular formation have been unclear. This paper reported that the neuropilin-1 mutant mouse embryos exhibited various types of vascular defects, including impairment in neural vascularization, agenesis and transposition of great vessels, insufficient aorticopulmonary truncus (persistent truncus arteriosus), and disorganized and insufficient development of vascular networks in the yolk sac. The vascular defects induced by neuropilin-1 deficiency in mouse embryos suggest that neuropilin-1 plays roles in embryonic vessel formation, as well as nerve fiber guidance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518505     DOI: 10.1242/dev.126.21.4895

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  247 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.

Authors:  Christiana Ruhrberg; Holger Gerhardt; Matthew Golding; Rose Watson; Sofia Ioannidou; Hajime Fujisawa; Christer Betsholtz; David T Shima
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

Review 3.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

Review 4.  Building a heart: implications for congenital heart disease.

Authors:  Deepak Srivastava
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

Review 5.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

Review 6.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

7.  Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.

Authors:  Usman Yaqoob; Sheng Cao; Uday Shergill; Kumaravelu Jagavelu; Zhimin Geng; Meng Yin; Thiago M de Assuncao; Ying Cao; Anna Szabolcs; Snorri Thorgeirsson; Martin Schwartz; Ju Dong Yang; Richard Ehman; Lewis Roberts; Debabrata Mukhopadhyay; Vijay H Shah
Journal:  Cancer Res       Date:  2012-06-27       Impact factor: 12.701

Review 8.  Axon guidance molecules in vascular patterning.

Authors:  Ralf H Adams; Anne Eichmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-31       Impact factor: 10.005

9.  Neurovascular development uses VEGF-A signaling to regulate blood vessel ingression into the neural tube.

Authors:  Jennifer M James; Cara Gewolb; Victoria L Bautch
Journal:  Development       Date:  2009-01-28       Impact factor: 6.868

10.  Inactivation of the Sema5a gene results in embryonic lethality and defective remodeling of the cranial vascular system.

Authors:  Roberto Fiore; Belquis Rahim; Vincent M Christoffels; Antoon F M Moorman; Andreas W Püschel
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.